University of West Attica
Ο ρόλος της βιταμίνης D στο ζεύγος εγκύου – νεογέννητου στην περιγεννητική περίοδο και η σχέση της με τις διατροφικές συνθήκες κι άλλους προσδιοριστικούς παράγοντες
Abstract
dc:descriptionVitamin D is a fat-soluble vitamin with numerous actions that are not only related to bone health and calcium metabolism. Vitamin D is enzymatically converted in the liver to 25-hydroxyvitamin D (25(OH)D), the major circulating form of vitamin D. There are two (commercially) available forms, D2 (ergocalciferol) and D3 (cholecalciferol). Vitamin D has a direct effect on the differentiation of chondrocytes and osteoblasts, for bone formation, but also on calcium-phosphorus metabolism, with a more specific effect on their intestinal and renal re-absorption. Low levels of 25(OH)D in the blood have been associated with the pathogenesis or progression of various chronic diseases such as diabetes mellitus (DM) type 2, metabolic syndrome, obesity, cardiovascular diseases, some forms of cancer, but also autoimmune diseases such as type 1 DM, multiple sclerosis, Crohn's disease, psoriasis vulgaris, etc. Several studies have associated maternal 25(OH)D deficiency [Vitamin D Deficiency / (VDD)] with adverse pregnancy outcomes such as pre-eclampsia, Caesarean section, gestational diabetes mellitus (GDM) and premature delivery, while in newborns with increased possibility of type 1 DM, low birth weight, hypokalemia attacks, reduced skeletal growth, low immunity, reduced lung maturation, bronchial asthma, allergic rhinitis and others. Pro-vitamin D3 is synthesized nonenzymatic-ally from the 7-dehydrocholesterol of the skin, after its exposure to the ultraviolet rays of sunlight. Vitamin D status is assessed by measuring blood 25(OH)D concentrations. 25(OH)D concentrations are a combination of sunlight exposure and diet. Reduced availability of vitamin D results from secondary insufficient dietary intake of vitamin D, fat malabsorption disorders, and/or lack of sunlight. The sun stimulates the production of vitamin D3 in the skin, which directly depends on the season, the person's age, skin pigmentation, the percentage of the person's body coverage through clothing and the use of sun protection products. The vitamin D status in the blood improves with a proper dietary intake of vitamin D (eating oily fish, vitamin D-fortified foods, milk, orange juices, etc.). Also, a high dietary calcium intake has a significant effect on the maintenance of 25(OH)D concentrations, as it increases the half-life of 25(OH)D.High-risk groups for VDD include the elderly, children, premature infants, pregnant women, institutionalized people of all kinds, people with low educational levels, dark-skinned people, people taking medications (corticosteroids, anti-epileptics, anti-tuberculosis, anti-fungals) , people with liver failure, people with malabsorption syndrome (Crohn's disease, ulcerative colitis, celiac disease, pancreatic insufficiency, fibro-cystic disease), people who lack exercise, with less sun exposure and exclusively vegetarians. All these people need a systematic intake of food supplements with vitamin D.Although vitamin D is extremely important for health, VDD is very common throughout the Western world. In fact, recently, there was talk of a European pandemic of 25(OH)D deficiency. Contrary to what was expected for the eastern and southern Mediterranean regions and despite the apparent sunshine, a high prevalence of low vitamin D status is observed. This phenomenon is called the "Mediterranean paradox" and as it turns out, it also concerns our country. Although Greece is characterized by prolonged sunshine, most Greeks seem to show a high percentage of VDD. The epidemiological study of the Hellenic Nutrition Society on the topic "The determination of vitamin D levels in a sample of the Greek population" proves that the problem of VDD concerns our country as well.As mentioned above, VDD has been considered by many as a factor in the occurrence of complications both in the mother herself and in her fetus-newborn. Therefore, 25(OH)D concentrations are of particular importance perinatally. Adequacy of 25(OH)D during pregnancy is necessary for the normal development of the fetal skeleton and ensuring the necessary reserves in the fetus. To date, many studies reveal a high correlation of maternal 25(OH)D concentrations with those of the newborn. What remains unclear to date is how exactly they interact with each other, especially when there is a severe lack of maternal 25(OH)D concentrations, but also how this correlation behaves in a Mediterranean country like Greece, in which sunshine favors vitamin D synthesis.In this study, we will try to assess the role of maternal VDD in the occurrence of possible perinatal complications. Also, the role of maternal VDD, at the end of pregnancy, in shaping the somatometric characteristics of the newborn will be assessed, in the light of receiving or not prenatal vitamin D supplementation. It is likely that maternal VDD in pregnancy is associated with reduced feto - neonatal development or the differentiation of neonatal somatometric characteristics. This is inferred based on the fact that fetal 25(OH)D concentrations appear to be directly dependent on maternal 25(OH)D concentrations. The few studies relating maternal 25(OH)D concentrations to neonatal anthropometrics are contradictory. However, several errors are found in the existing studies, which may lead to different conclusions. In any case, it is considered necessary to study the previous correlation in different weeks of pregnancy, taking into account the body mass index (BMI) of the pregnant woman (before and at the end of pregnancy) but also the interpretation of the results by country in which the study is conducted, given the difference in sunshine and the different times the samples are taken. Also, we will investigate the possible effect of maternal VDD on the value of neonatal capillary bilirubin, on the third day of life of the newborns. To date, the studies that have investigated the above association are few and mainly concern an Asian and not a Mediterranean population. Certainly, more prospective studies are needed to clarify the role of maternal 25(OH)D concentrations in the pathogenesis of neonatal hyperbilirubinemia. Finally, we will assess the prevalence of maternal and neonatal VDD in Greece, assessing maternal 25(OH)D concentrations at the end of pregnancy, taking into account the effect of prenatal vitamin D supplementation administered during pregnancy. The aim of our study is to interpret, if finally, the systematic introduction of prenatal vitamin D supplements helps to reduce unwanted pregnancy complications.The present study was carried out at the "Tzaneio" General Hospital of Piraeus. The blood samples collected were analyzed in the biochemical laboratory of the hospital, with the consent of the director of the biochemical department, Mrs. Tselepi, the sector and the hospital administration. The study protocol was reviewed and approved by the hospital's scientific board. Our study only concerned Greek pregnant women or pregnant women who were born or have been living permanently in Greece, for more than a decade, benefiting from the Mediterranean sun of our country. Data were collected from 248 pairs of healthy Greek mothers and their newborns. We chose to do a cross-sectional study, as we determined the role of maternal 25(OH)D concentrations on maternal and neonatal pregnancy outcomes, only at the specific moment of delivery and not throughout pregnancy. The pregnant women who came and gave birth at the Obstetrics and Gynecology clinic of "Tzaneio", were divided into those who received a vitamin D supplement of 400-800 IU together with calcium and those who did not receive any type of supplement, in order to assess the effect of prenatal of vitamin D supplementation. Data on mothers were collected at the onset of labor while those on neonates were collected immediately after birth. Maternal 25(OH)D concentrations were determined by blood sampling. The blood samples of the mothers were taken by the midwives. The mother was always accompanied by a history with her demographic characteristics, her phenotypic characteristics, her BMI at the beginning of the pregnancy, the change in her weight during pregnancy, any preexisting diseases of the pregnancy, her eating habits, her lifestyle, her educational level, her socioeconomic situation, any use of pharmaceutical preparations and the recording of possible choices in the present pregnancy. The mother-newborn pairs were categorized by season into two groups (Spring – Summer, Winter – Autumn). Also, neonatal 25(OH)D concentrations of the umbilical cord at birth, immediately after its ligation, and capillary bilirubin, on the third day of life of the newborns, were determined and evaluated. At birth, neonates' sex and biometrics such as height, weight, head circumference, abdominal circumference, chest circumference, femur length and forearm length were recorded. According to the American Endocrinology Society, patients were divided into those with: a) adequate 25(OH)D concentrations (>30 ng/ml) b) insufficient 25(OH)D concentrations (21-29 ng/ml) c) deficient 25(OH)D concentrations (<20 ng/ml) and d) severely deficient 25(OH)D concentrations (<12 ng/ml). According to the adequacy criteria of the American Pediatric Endocrinology Society, the newborns of the mothers of each category were divided, like their mothers, into newborns with a) adequate of 25(OH)D concentrations (>30 ng /ml), b) deficient of 25(OH)D concentrations (16-29 ng/ml), c) lack of 25(OH)D concentrations (≤15 ng/ml) and d) severely lack of (<12.5 ng/ml ml).Finally, with this investigation, we aim to provide the scientific community with the existing knowledge about vitamin D, which health professionals can use, to offer the maximum in the prevention of VDD, its treatment, and the avoidance of its unwanted complications.
Degree
thesis:*- Grantor dc:publisher
- University of West Attica
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kokkinari, Artemisia
- Κοκκινάρη, Αρτεμισία
Subjects
dc:subject × 31- Βιταμίνη D
- Περιγεννητική περίοδος
- Εγκυμοσύνη
- Έγκυος γυναίκα ( Κύηση )
- Νεογέννητο
- Διατροφή
- Vitamin D
- Perinatal period
- Pregnancy
- Pregnant
- Newborn
- Vitamina D
- Periodo perinatale
- Gravidanza
- Incinta
- Neonato
- Dieta
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Επαγγέλματα υγείας
- Επιστήμες υγείας, γενικά
- Άλλες Ιατρικές Επιστήμες
- Ιατρική, άλλοι τομείς
- Ιατρική έρευνα και Πειραματική ιατρική
- Health Sciences
- Medical and Health Sciences
- Health Professions
- Health sciences, general
- Other Medical Sciences
- Medicine, miscellaneous
- Research and Experimental medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/57082